Topical Application of Preserved and Unpreserved Bevacizumab Eye Drops Improves Ocular Surface Parameters in Dogs with Chronic Keratitis: A Pilot Study
-group, and fluorescein uptake in the B-group. Both formulations were safe and well tolerated. These preliminary findings suggest that topical bevacizumab may have potential benefits for CNV and ocular surface disorders in dogs, although larger studies are needed.
Authors
- Alexander Tichy (ORCID: https://orcid.org/0000-0001-8668-3858)
- Stefan Kummer (ORCID: https://orcid.org/0000-0002-0746-1403)
- Michael Wambacher (ORCID: https://orcid.org/0000-0002-8668-0400)
- Ulrike Lessiak
- Barbara Nell
Institutions
- University of Veterinary Medicine Vienna (AT)
- Vienna General Hospital (AT)
Publication Details
- Journal
- Veterinary Sciences
- Published
- 2026-04-17
- DOI
- https://doi.org/10.3390/vetsci13040388
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Veterinärmedizinische Universität Wien